PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

inhibrx-bio-investor-deck-august-2024 - Inhibrx | Presentation Nation

HomepageInhibrxinhibrx-bio-investor-deck-august-2024

inhibrx-bio-investor-deck-august-2024

Inhibrx

Browse presentations, reports, and documents from Inhibrx.

Tags

2024

Filter options

All (9)●
brochure (1)○
conference (1)○
investor_presentation (3)○
presentation (4)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

inhibrx-bio-investor-deck-august-2024 by Inhibrx.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Inhibrx

cdda0542d9e657a586264c4ce965b5b3e11a

brochure

INBRX-106 Hexavalent Anti-OX40 Agonist Inhibrx Solid Tumors

investor_presentation

Similar presentations from other companies

NetScout Systems_May_2021_400_69400

presentation

NetScout Systems

Iron Mountain_May_2020_263_55263

presentation

Iron Mountain

Denny's_January_2017_239_4239

investor_presentation

1 Pages

Inhibrx 2022 Investor Presentation - Clinical Pipeline Update

investor_presentation

investor_presentation

46 Pages

Inhibrx INBRX-109 Phase 1 Ewing Sarcoma Clinical Trial 2021

conference

1 Pages

Inhibrx INBX Investor Presentation September 2023

investor_presentation

investor_presentation

36 Pages

Inhibrx-Presentation-August-2021

presentation

presentation

Denny's Corporation

caremax-investor-day-march-2023_vpost

presentation

CareMax

Cengage Group_June_2024_916_101916

presentation

Cengage

Fate Therapeutics_February_2022_127_79127

presentation

Fate Therapeutics